The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.
Författare
Summary, in English
Prostate-specific antigen (PSA) testing has limited accuracy for the early detection of prostate cancer (PCa).
Publiceringsår
2014
Språk
Engelska
Sidor
1109-1115
Publikation/Tidskrift/Serie
European Urology
Volym
66
Issue
6
Fulltext
- Available as PDF - 632 kB
- Download statistics
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
Elsevier
Ämne
- Urology and Nephrology
Status
Published
Forskningsgrupp
- Clinical Chemistry, Malmö
ISBN/ISSN/Övrigt
- ISSN: 1873-7560